National Physicians Alliance

Committed to Advancing the Core Values of the Medical Profession:

Service, Integrity, and Advocacy



Letters, Joint Statements & Endorsements

Below are joint statements, amici briefs, and letters endorsed by the National Physicians Alliance:

Coalition Letter on FDA’s Limited Population Pathway for Antibacterial and Antifungal Drugs (August 2018)

Coalition Sign-On Letter on SCOTUS Nominee and Health Care Stakes (August 2018)

Health Care Stakeholders Coalition Sign-On Letter Opposing Renewed ACA Repeal  (July 2018)

Coalition Public Comments on HHS Blueprint on Prescription Drug Costs (July 2018)

Coalition Letter to House – PAHPA Antibiotic Incentives Concerns (June 2018)

Coalition Letter to HHS on Increasing Transparency of Rx Prices (May 2018)

Coalition Letter Opposing CHIP Recission (May 2108)

Health Scientists Letter Requesting Extension EPA Polluted Science Rule (May 2018)

NPA-NHCR Comments on New Treatment for Antibiotic-Resistance Bacteria-Plazomicin (May 2018)

NPA Letter of Thanks to Rep. DeLauro for Shining Light on Deaths Associated with Nuplazid (April 2018)

NY Doctors Coalition Memo of Support for A9594_S7569 Temporary Protected Status (April 2018)

NY Doctors Coalition Letter on A8054A Child Health Plus expansion (April 2018)

March for Science Coalition Letter Calling for Evidence-based Policies to Prevent Gun Violence (March 2018)

Coalition Letter in Support of the Public Service Loan Forgiveness Program (March 2018)

Coalition Letter in Support of the Patient Advocacy Transparency Act (March 2018)

Coalition Letter Urging Stabilization Package for the Individual Health Insurance Market (March 2018)

Coalition Letter following Parkland, Florida High School Massacre (February 2018)

Coalition Letter to Florida Officials following MSD High School Shooting (February 2018)

Coalition Letter Urging Congress Not to Harm Medicaid or the ACA in 2018  (January 2018)

First Focus Coalition Letter Calling on Congress Protect the Children’s Health Insurance Program (December 2017)

Coalition Letter in Support of Healthy Families Act (December 2017)

Coalition Letter Opposing Workflex in the 21st Century Act (December 2017)

Coalition Letter Expressing Concerns on Tax Bill (December 2017)

Coalition Letter Opposing Azar HHS Nomination (December 2017)

60 Public Health Groups Letter on Tax Legislation (November 2017)

Coalition Letter Addressing Tax Bill Health Impact (November 2017)

NY Physicians Coalition Letter to Senate Leadership Opposing Individual Mandate Repeal Tax Cuts and Jobs Act (November 2017)

NY Physicians Coalition Letter on Tax Bill (October 2017)

Coalition Letter on CREATES Acts (September 2017)

Coalition Letter on ACA Cost-Sharing Payments(August 2017)

Coalition Letter Opposing Harmful Medicaid Stereotypes (July 207)

NPA Letter to Senate HELP Committee re Gottlieb FDA Nomination (April 2017)

Allies Sign-on Letter to Senate Leaders re Gottlieb FDA Nominee, Opioids & Heroin Epidemic (April 2017)

Letter from Public Health Groups Opposing De-regulation of e-cigarettes and cigars H.R. 1136 (March 2017)

NPA letter to ACGME re Common Program Requirements for Resident Duty Hours in the Learning and Working Environment (September 2016)

Coalition Comments  to FDA re Labeling for Biosimilar Products (August 2016)

Letter to State Dept re Intellectual Property & Access to Medicines (July 2016)

Letter to Senate in support of Gun Regulation Amendments (June 2016)

Letter to Senate HELP Cmte Leaders re 21st Century Cures (May 2016)

Coalition Comments to FDA re Direct-to-Consumer Advertising (April 2016)

NPA Comments on CA Bill-AB533 – Protect Patients from Surprise Out-of-Network Bills (April 2016)

NPA Comments on FDA Generics Labeling to US House Appropriation and Agriculture Committees  (April 2016)

US TPP public health letter (April 2016)

FOCR sign on letter regarding regulation of laboratory developed tests (LDT)_Senate (April 2016)

FOCR sign on letter regarding regulation of laboratory developed tests (LDT)_House (April 2016)

Medical Organizations Call for CDC Funding for Gun Violence Research (April 2016)

Non-Profit Groups Urge Obama Administrations, NIH to Lower Price of Government-Funded $129,000 Per Year Prostate Cancer Drug (March 2016)

Comments of members of the Patient, Consumer, and Public Health Coalition on the FDA Draft Guidance entitled “Over-the-Counter Sunscreens: Safety and Effectiveness Data” (March 2016)

Comments on Proposed Rule: Restricted Sale, Distribution, and Use of Sunlamp Products (March 2016)

NPA comments re tanning beds, Docket ID FDA-2015-N-1765 (March 2016)

FDA Generics Labeling Letter to Admin (March 2016)

NPA Comments to Senate Finance Committee – Senators Grassely & Wyden  re High Drug Prices (March 2016)

In-N-Out Coalition Letter (February 2016)

PCPH Coalition letter to HELP (February 2016)

NPA Comments to Senator Murray re Senate HELP Preventable Tragedies Report (January 2016)

NPA comments re CDC opioid guidelines (January 2016)

Lift CDC Gun Violence Research Ban – Medical Organizations Sign-on Letter to Congress (December 2015)

Comments of members of the Patient, Consumer, and Public Health Coalition on the Establishment of the Patient Engagement Advisory Committee (November 2015)

Letter to the FDA Regarding Medical Device Patient Labeling (October 2015)

Provider Letter in Support of Planned Parenthood Federation of America (September 2015)

Letter Regarding Nicotine Exposure Warnings and Child-Resistant Packaging for Liquid Nicotine, Nicotine- Containing E-Liquid(s), and Other Tobacco Products; Docket No. FDA-2015-N-1514 (September 2015)

Letter-to-the-US-Chain-Restaurant-Industry (September 2015)

Provider Letter Opposing S 1553 (September 2015)

Letter to US Senate Finance Committee Regarding Opioid Findings (September 2015)

21st Century Cures Act ( H.R. 6) – NPA Physicians Urge Caution – U.S. Senate letter – U.S. House letter (June 2015)

Capps Coalition Ltr Re: 21st Century Cures Act and the inclusion of children and seniors in clinical trials (June 2015)

Letter to Ways & Means Committee re 21st Century Cures Act, Section 3041 (re industry payment for CME – June 2015)

Letter Regarding H.R. 36, Pain-Capable Unborn Child Protection Act (May 2015)

Letter Regarding Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products (April 2015)

NPA Support for the Pharmaceutical Cost Transparency Act of 2015 – AB 463 (April 2015)

Letter about the impact that the Trans-Pacific Partnership (TPP) and the Trans-Atlantic Trade and Investment Partnership (T-TIP) could have on health care (April 2015)

Statement of Members of the Coalition to Protect the Patient-Provider Relationship Regarding Mandating that Health Care Professionals Provide Unsubstantiated Medical Information (April 2015)

NPA & ACP Testimony to CT General Assembly Judiciary Committee re SB 650/HB 6848 and HB 6962 addressing gun violence prevention and safe storage (March 2015)

NPA letter re S. 185, the Promise for Antibiotics and Therapeutics for Health (PATH) Act (March 2015)

NPA & ACP Testimony to CT General Assembly Appropriations Committee on Tobacco Cessation Funding (March 2015)

Letter in Support of the ACA and the Medical Device Tax (January 2015)

H.R. 36 Letter from Provider Community (January 2015)

Comments on the proposed order to reclassify External Pacemaker Pulse Generator devices and Pacing System Analyzers (December 2014)

NPA-CT Comments on Waterbury Hospital Merger (December 2014)

Letter to the President re: trade negotiations (December 2014)

Letter regarding public health opposition to HR4012 and 1422 (November 2014)

Letter to Reps DeGette, Upton & Pitts Regarding FDA Off-Label-Use Procedure Changes (November 2014)

Commentary Regarding the Purchase of Waterbury Hospital and St. Mary’s Hospital by Tenet (October 2014)

Chantix Petition (October 2014)

Comments of Members of the Patient, Consumer, and Public Health Coalition on Draft Guidance “Intent to Exempt Certain Class II and Class I Reserved Medical Devices from Premarket Notification Requirements” (October 2014)

Comments of Members of the Patient, Consumer, and Public Health Coalition on Draft Guidance “Intent to Exempt Certain Class II and Class I Reserved Medical Devices from Premarket Notification Requirements” (October 2014)

Comments of members of the Patient, Consumer, and Public Health Coalition on the Proposed Rule, “Medical Device Classification Procedures” (September 2014)

Letter in support of the FDA’s proposed regulations to allow generic drug makers to initiate safety updates to their product labels (September 2014)

Comments of members of the Patient, Consumer, and Public Health Coalition on the Draft Guidance “Appropriate Use of Voluntary Consensus Standards in Premarket Submissions for Medical Devices” (August 2014)

Letter to Senate Judiciary Committee and all Senators: National Physicians Alliance Supports Federal Legislation to Protect Domestic Violence Victims from Guns in the Hands of their Abusers (July 2014)

Letter to Congress re: Pregnant Workers Fairness Act (July 2014)

Letter to Senate Appropriations Cmte re: price discounts for tobacco (July 2014)

Letter in Support of the Women’s Health Protection Act of 2013 (June 2014)

Letter to U.S. Senators & House Representatives re NPA Support for CDC Funding for Gun Violence Prevention Research (June 2014)

Letter to House Appropriations Chair & Ranking Member re opposition to Cigar Exemption from FDA regulation (May 2014)

Letter to Dr. Hamburg re HPV Test (April 2014)

Letter to Rep. Slaughter in support of H.R. 1150, the Preservation of Antibiotics for Medical Treatment Act (March 2014)

NPA Comments to CMS re “Healthy Pennsylvania” Proposal (March 2014)

NPA-CT Comments on State of Connecticut Behavioral Health Plan General Assembly Public Act 13-178  (March 2014)

Letter to Secretary Sebelius re comprehensive tobacco cessation benefit (February 2014)

Letter to House Energy & Commerce Cmte opposing H.R. 3303, the SOFTWARE Act of 2013 (February 2014)

NPA Letter opposing the Antibiotic Development to Advance Patient Treatment Act of 2013 (ADAPT), H.R. 3742, to members of U.S. House Energy & Commerce Sub Committee on Health, and U.S. Senate Health, Education, Labor & Pension Committee (February 2014)

Comments to FDA re proposed changes to labeling for approved drugs & biologics (February 2014)

Letter to Congresswoman Rosa DeLauro in support of strengthening FDA safeguards  (February 2014)

Comments submitted to FDA re draft guidance on pharmacy compounding (February 2014)

NPA-CT Comments on the Connecticut Healthcare Innovation Plan Draft (December 2013)

Medicaid Coalition Letter on Extenders (to Senate Finance) (to House Ways & Means) (December 2013)

Letter supporting CMS regulations re: Sunshine Act Provisions of ACA (November 2013)

Letter submitted to FDA re: down-classification of cardiac device (September 2013)

Comments submitted to FDA re: antibacterial drug development (August 2013)

Comments submitted to FDA re: risk categorization of cardiac devices (August 2013)

Letter to Senate Appropriations Committee on Funding for Research on Gun Violence
(July 2013)

Letter to OMB calling for rule on Unique Device Identification System (July 2013)

Letter to Senator Rockefeller in Support of Pregnant Women and Children (June 2013)

Letter to Senate Finance Committee re: Sustainable Growth Rate (SGR) and Payment Reform (May 2013)

NPA Raises Concerns over Health Impacts of Current Border Security, Economic Opportunity, and Immigration Modernization Act (April 2013)

Letter to Congress Calling for Sustainable Growth Rate (SGR) Repeal and Payment Reform (April 2013)

NPA Letter to U.S. Senators–Vote for Commonsense Gun Laws (April 2013)
(Letter to Sen. Reid linked here, individualized letters were sent to each senator.)

Letter to CMMS calling for multiple-language translations of applications for insurance affordability programs (Feb 2013)

Comments submitted to FDA re: proposed Alternative Pathway for Drug Approvals (Jan 2013)

NPA Comments submitted to Vice President Biden’s Taskforce on Gun Violence Prevention (Jan 2013)

Letter to White House re HHS Physician Payment Sunshine Act regulations (Jan 2013)

Letter to FDA in support of Unique Device Identifier system (Nov 2012)

Letter to MA Department of Health re Pharmaceutical and Medical Device Manufacturer Gift Ban (Sept 2012)

Letter to House E&C Committee re HR 1206, affecting Medical Loss Ratio calculations (Sept 2012)

Letter to PA policymakers re: Essential Health Benefits Package (Sept 2012)

Letter to Congress in support of the Agency for Healthcare Research and Quality (July 2012)

Letter to HHS Secretary Kathleen Sebelius Calling for Surgeon General’s Report on Health Effects of Soda and Other Sugary Drinks (July 2012)

Press Release:  NPA Joins Allies Urging Massachusetts Gift Ban Veto (July 2012)

Letter to MA Gov. Patrick re: Pharmaceutical and Medical Device Gift Ban and Disclosure Law (June 2012)

Letter to Congress re Children’s Health Insurance Program Reauthorization Act (May 2012)

Joint Comments to the Senate HELP Committee re GAIN Act (April 2012)

Letter of thanks to HHS Secretary Sebelius for bold anti-smoking campaign (Mar 2012)

Letter in support of SOUND Act, Safety of Untested & New Devices (Feb 2012)

Amicus Brief Submitted to US Supreme Court re Minimum Coverage Provision of ACA (Jan 2012)

Letter to House E&C & Senate HELP Committees re Safe Drug Supply Chain (Nov 2011)

NPA recommendations to HHS on Essential Health Benefits (Nov 2011)

Letter delivered to members of the Joint Select Committee on Deficit Reduction (Oct 2011)

Letter opposing H.R. 1639, which would exempt many cigars from regulation
under the Family Smoking Prevention and Tobacco Control Act (Sept 2011)

Letter to Senator Grassley in thanks for his support of Physician Payment Sunshine Act provisions of ACA (Sept. 2011)

Letter to FDA Commissioner re Conflict of Interest Restrictions for advisory panels (August, 2011)

Letter to FDA re: Medical Device User Fee Act reauthorization process (July, 2011)

Letter to US Leaders regarding Cuts to Medicaid (July 2011)

Letter to US House Appropriations Committee opposing cuts to FDA (May, 2011)

Letter to Congress Opposing Cuts to Medicaid (May, 2011)

Letter to US House of Representatives in support of Drug Safety bill HR 1483 (Apr, 2011)

Letter supporting USDA proposed rule on school nutrition standards (Apr, 2011)

Letter to President Obama re Maxwell-Jolly (Mar, 2011)

Health Groups Letter Opposed to HR3 358 (Feb, 2011)

HCAN Comments to CMS on Establishment of State-Level Exchanges (Oct, 2010)

Call for Ban of Anti-Personnel Landmines (June, 2010)

Comments re: Health Insurance Rate Authority Act (May, 2010)

Amici Briefs:

Whole Woman’s Health, Et. Al. v. Kirk Cole, M.D., Commissioner of the TX Dpt of State Health Services, Et. Al. (Jan 2016)

March-of-Dimes-amicus-King-Burwell-case (Jan 2015)

ACOG, PRH, AAP, ANA Hobby Lobby Amicus Brief (Jan 2014)

Amicus Brief Submitted to US Supreme Court re Minimum Coverage Provision of ACA (Jan 2012)

TMLC 6th Cir. Brief FINAL (Jan 2011)

Liberty University FINAL-4th circuit (Feb 2011)

Florida v. HHS providers brief–11th circuit (April 2011)

Amicus Brief for the New England Journal of Medicine

Physicians Amicus Brief (Corrected Sept 2009)


The ABIM Foundation’s Physician Charter on Medical Professionalism

Institute of Medicine Principles for “Insuring America’s Health”

Pledges and Partnerships:

Coalition to Protect Women’s Health Care

Campaign for Tobacco-Free Kids

Patient, Consumer, and Public Health Coalition

Partnership for Patients

National Partner, Nonprofit VOTE

Join Us

Become an NPA Member »

Medical Student?
Learn more »

Not a Physician?
Become a Friend of the NPA »

Get NPA Email Updates

Read our Report

Politics in the Exam Room - A Growing Threat



Responsible Prescribing

Dot A

Limiting Pharma's Influence

The NPA encourages all physicians to join our Unbranded Doctor network — prescribers committed to reducing the influence of pharmaceutical marketing on our profession.

Learn More

Take Action

NPA Flickr Feed

View More